Arrowstreet Capital Limited Partnership Has $75.34 Million Stake in The Clorox Company $CLX

Arrowstreet Capital Limited Partnership lowered its stake in The Clorox Company (NYSE:CLX) by 55.1% in the first quarter, Holdings Channel reports. The fund owned 727,015 shares of the company’s stock after selling 892,381 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Clorox were worth $75,341,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. State Street Corp increased its position in Clorox by 3.5% during the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after purchasing an additional 282,794 shares in the last quarter. Invesco Ltd. lifted its stake in shares of Clorox by 22.1% in the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after acquiring an additional 884,751 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Clorox by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after acquiring an additional 10,060 shares in the last quarter. Van ECK Associates Corp boosted its holdings in shares of Clorox by 15.7% during the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after acquiring an additional 426,433 shares in the last quarter. Finally, Two Sigma Investments LP grew its position in Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after acquiring an additional 439,797 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.63% of the stock is owned by corporate insiders.

Clorox Stock Performance

Shares of CLX stock opened at $95.61 on Monday. The stock has a market capitalization of $11.56 billion, a PE ratio of 15.52 and a beta of 0.54. The business’s 50 day simple moving average is $95.10 and its 200 day simple moving average is $103.85. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a one year low of $84.70 and a one year high of $131.86.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the company earned $1.45 EPS. The company’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, research analysts forecast that The Clorox Company will post 5.52 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CLX. Jefferies Financial Group lowered their target price on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $94.00 price target on shares of Clorox in a report on Wednesday. Barclays upped their price objective on Clorox from $85.00 to $86.00 and gave the company an “underweight” rating in a research note on Tuesday, July 21st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. Finally, TD Cowen lifted their target price on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of “Reduce” and a consensus price target of $102.80.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.